Abstract
The levels of flurithromycin in gynecological tissue in 20 female patients were studied after preoperative administration. The tissue flurithromycin levels obtained were comparable to those obtained in serum at 3 and 4 h but were frequently higher than those in serum at 6 and 12 h. Flurithromycin reached the highest concentrations in ovary at 4 h and in endometrium at 6 h.
Full Text
The Full Text of this article is available as a PDF (181.5 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bariffi F., Clini V., Ginesu F., Mangiarotti P., Romoli L., Gialdroni-Grassi G. Flurithromycin ethylsuccinate in the treatment of lower respiratory tract bacterial infections. Infection. 1994 May-Jun;22(3):226–230. doi: 10.1007/BF01716716. [DOI] [PubMed] [Google Scholar]
- Benoni G., Cuzzolin L., Leone R., Consolo U., Ferronato G., Bertrand C., Puchetti V., Fracasso M. E. Pharmacokinetics and human tissue penetration of flurithromycin. Antimicrob Agents Chemother. 1988 Dec;32(12):1875–1878. doi: 10.1128/aac.32.12.1875. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cocuzza C. E., Mattina R., Lanzafame A., Romoli L., Lepore A. M. Serum levels of flurithromycin ethylsuccinate in healthy volunteers. Chemotherapy. 1994 May-Jun;40(3):157–160. doi: 10.1159/000239187. [DOI] [PubMed] [Google Scholar]
- Ellner P. D., Neu H. C. The inhibitory quotient. A method for interpreting minimum inhibitory concentration data. JAMA. 1981 Oct 2;246(14):1575–1578. doi: 10.1001/jama.246.14.1575. [DOI] [PubMed] [Google Scholar]
- Fernandes P. B., Hardy D. J. Comparative in vitro potencies of nine new macrolides. Drugs Exp Clin Res. 1988;14(7):445–451. [PubMed] [Google Scholar]
- Fietta A., Boeri P., Colombo M. L., Merlini C., Gialdroni Grassi G. Uptake of flurithromycin by human polymorphonuclear phagocytes: partial characterization of the entry mechanism. Chemotherapy. 1992;38(6):433–440. doi: 10.1159/000239039. [DOI] [PubMed] [Google Scholar]
- Furneri P. M., Bisignano G., Cerniglia G., Tempera G., Nicoletti G. In-vitro antimycoplasmal activity of flurithromycin. J Antimicrob Chemother. 1995 Jan;35(1):161–165. doi: 10.1093/jac/35.1.161. [DOI] [PubMed] [Google Scholar]
- Furneri P. M., Tempera G., Lepore A. M., Bonfanti C., Nicoletti G. In vitro activity of flurithromycin against some genital pathogens. Drugs Exp Clin Res. 1991;17(3):175–180. [PubMed] [Google Scholar]
- Hardy D. J., Hensey D. M., Beyer J. M., Vojtko C., McDonald E. J., Fernandes P. B. Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides. Antimicrob Agents Chemother. 1988 Nov;32(11):1710–1719. doi: 10.1128/aac.32.11.1710. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kirst H. A., Sides G. D. New directions for macrolide antibiotics: pharmacokinetics and clinical efficacy. Antimicrob Agents Chemother. 1989 Sep;33(9):1419–1422. doi: 10.1128/aac.33.9.1419. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kirst H. A., Sides G. D. New directions for macrolide antibiotics: structural modifications and in vitro activity. Antimicrob Agents Chemother. 1989 Sep;33(9):1413–1418. doi: 10.1128/aac.33.9.1413. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kroening U., Liebig S., Wundschock M. Tobramycin-Spiegel im menschlichen Lungengewebe. Infection. 1978;6(5):231–235. doi: 10.1007/BF01642315. [DOI] [PubMed] [Google Scholar]
- Lepore A. M., Bonardi G., Maggi G. C. Influence of food on the absorption of flurithromycin in man. Int J Clin Pharmacol Res. 1988;8(4):253–257. [PubMed] [Google Scholar]
- Neu H. C., Ellner P. D. The inhibitory quotient. Bull N Y Acad Med. 1983 Jun;59(5):430–442. [PMC free article] [PubMed] [Google Scholar]
- Toscano L., Fioriello G., Spagnoli R., Cappelletti L., Zanuso G. New fluorinated erythromycins obtained by mutasynthesis. J Antibiot (Tokyo) 1983 Nov;36(11):1439–1450. doi: 10.7164/antibiotics.36.1439. [DOI] [PubMed] [Google Scholar]